<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
	<channel>
		<title>Huvepharma</title>
		<link>http://www.huvepharma.com/</link>
		<description></description>
		<language>en</language>
 		<item>
 			<title>Huvepharma introduces Lianol, a fermented potato protein, with pro-metabolic activity</title>
 			<link>http://www.huvepharma.com/news/?n=23</link>
 			<guid>http://www.huvepharma.com/news/?n=23</guid>
 			<description><![CDATA[<p align="right"><strong>PRESS RELEASE</strong></p>
<p align="right">Antwerp, January 2010</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><strong>Natural proteins dictating the future</strong></p>
<p>Huvepharma is a young, ambitious world player on the market of veterinary products and feed additives who regularly brings innovations and product introductions.&nbsp; It has gained a strong position in the demanding segment of intensive live stock production thanks to its dedication and high quality products.</p>
<p>The intensive live stock production has changed dramatically over the years and farmers and integrators are continuously looking for possibilities to improve health status and production levels through clever use of new management systems and feed supplements.&nbsp; Various reputable scientists strongly believe in the positive effects natural products can have on metabolic processes.&nbsp; Reaching improved immunity levels results in higher health status and inherently means reaching higher productivity levels.&nbsp; A large number of natural complementary feeding stuff products have been screened over the years but only a limited selection can deliver and live up to these expectations.&nbsp; Huvepharma is introducing a perfect example of such a product, Lianol&reg;, a highly digestible fermented potato protein of which the use results in pro-metabolic peptides in food producing animals.&nbsp; Lianol&reg; was developed by Ardol BV, Netherlands.</p>
<p>&nbsp;</p>
<p><strong>Performance increase with Lianol&reg;</strong></p>
<p>The unfavorable effect of the Negative Energy Balance on pig fertility and performance has been studied in depth and is largely documented in multiple academic circles.&nbsp; Various forms of metabolic stress reduce the capacity of the liver cells to produce its normal endocrine metabolic peptides and related functions.&nbsp; Low levels hereof can cause impaired fertility, retarded growth, impaired feed conversion and reduced immunity.&nbsp; Lianol&reg; administration supports the capacity of the liver to produce the necessary and needed physiological metabolic peptides.&nbsp; All this results in a better natural immunity, enhanced natural heat, shorter weaning to insemination period and reduced number of empty days in sows, all inducing a better and restored liver function and metabolism.</p>
<p>&nbsp;</p>
<p><strong>More piglets, more benefit</strong></p>
<p>With the benefits of Lianol&reg; use in sows confirmed, the effect on the piglets was also studied.&nbsp; It was found that the litters of Lianol&reg; treated sows were not only larger, they also produced more weaned piglets and mortality levels were considerably lower than untreated sows.&nbsp; Detailed results will be presented at the International Porcine Veterinary Society (IPVS) 2010, Vancouver.</p>
<p>&nbsp;</p>
<p><strong>Range addition</strong></p>
<p>The combination of these findings with improved piglet immunity levels, higher milk production in sows, optimal standing heat, less empty days and even an increased boar libido and higher seamen quality was convincing enough for Huvepharma to include Lianol&reg; in its broad world-wide available product range and to provide these product benefits to customers.&nbsp; Next to the obtained results in pig production, Huvepharma is supporting research to develop use of Lianol&reg; for other species.</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p align="right">Lianol&reg; brand is owned by Ardol BV, Netherlands</p>
<p>&nbsp;</p>]]></description>
 			<pubDate>Fri, 22 Jan 2010 00:00:00 +0200</pubDate>
 		</item>
 		<item>
 			<title>Huvepharma at VIV Europe 2010</title>
 			<link>http://www.huvepharma.com/news/?n=21</link>
 			<guid>http://www.huvepharma.com/news/?n=21</guid>
 			<description><![CDATA[<p>Dear Customers.</p>
<p>We are pleased to invite you to the upcoming International VIV Utrecht 2010 fair taking place from 20-22 April 2010 in the Jaarbeurs Exhibition Centre in Utrecht, Netherlands to visit our booth.</p>
<p>During this fair you will be able to meet and greet our International staff and learn about our new projects and products.</p>
<p>Please already note down our booth number 09.C070</p>
<p>To register for a VIV visit, please use the following link: <a href="https://www.databadge.net/vive2010/reg/?link=a28ce0ce27bbb2e7e13b">https://www.databadge.net/vive2010/reg/?link=a28ce0ce27bbb2e7e13b</a></p>
<p>See you all there</p>]]></description>
 			<pubDate>Mon, 21 Dec 2009 00:00:00 +0200</pubDate>
 		</item>
 		<item>
 			<title>HydroDoxx - the new member in our veterinary range</title>
 			<link>http://www.huvepharma.com/news/?n=22</link>
 			<guid>http://www.huvepharma.com/news/?n=22</guid>
 			<description><![CDATA[<p>Dear Customers.</p>
<p>To complete our veterinary portfolio we are happy to introduce our EU registered "easy soluble" HydroDoxx 500 mg/ml water soluble formula containing Doxycycline hyclate. This formulation is easy soluble in all types of drinking water and is registered for Poultry and Pigs. Please consult your local EU representative to obtain the country specific information.</p>
<p>HydroDoxx 500 is available in aluminium bags of 1 kg .</p>]]></description>
 			<pubDate>Mon, 21 Dec 2009 00:00:00 +0200</pubDate>
 		</item>
 		<item>
 			<title>New veterinary website coming soon</title>
 			<link>http://www.huvepharma.com/news/?n=20</link>
 			<guid>http://www.huvepharma.com/news/?n=20</guid>
 			<description><![CDATA[<p>Huvepharma will launch a new special veterinary website which will be available for registered users and veterinarians. This website will facilitate our customers' needs like informing them about the different SPC's and technical information linked to our EU 27 veterinary product range.</p>]]></description>
 			<pubDate>Tue, 20 Oct 2009 00:00:00 +0300</pubDate>
 		</item>
 		<item>
 			<title>Huvepharma broadens its registrations of veterinary products in the EU countries</title>
 			<link>http://www.huvepharma.com/news/?n=19</link>
 			<guid>http://www.huvepharma.com/news/?n=19</guid>
 			<description><![CDATA[<p>Huvepharma is committed to add performance to the Veterinary Health Industry too. We have developed our veterinary products from plain active ingredients to highly customized formulations and finished veterinary products that meet the highest possible standards and levels of convenience for the end users.</p>
<p>So far, we developed three different ranges of veterinary products - Tilmovet range, Pharmasin range, and Vetmulin range. &nbsp;</p>
<p>We work continuously on registering our veterinary products in the EU countries. We already have different EU registered formulations from these three ranges in various countries, for more info please contact our local EU sales managers.</p>]]></description>
 			<pubDate>Fri, 11 Sep 2009 00:00:00 +0300</pubDate>
 		</item>
 		<item>
 			<title>Huvepharma will be present at ESPN</title>
 			<link>http://www.huvepharma.com/news/?n=18</link>
 			<guid>http://www.huvepharma.com/news/?n=18</guid>
 			<description><![CDATA[<p>Huvepharma is a sponsor of the 17-th European Symposium on Poultry Nutrition which will take place from 23-th to 27-th August 2009 in Edinburgh, Scotland.</p>
<p>Our company will participate in the scientific sections, please look into the published abstracts and posters.</p>]]></description>
 			<pubDate>Tue, 04 Aug 2009 00:00:00 +0300</pubDate>
 		</item>
 		<item>
 			<title>Huvepharma vet range grows</title>
 			<link>http://www.huvepharma.com/news/?n=16</link>
 			<guid>http://www.huvepharma.com/news/?n=16</guid>
 			<description><![CDATA[<p>Our
company markets a steadily expanding range of veterinary products in the
segment of macrolides . Unique formulation capacities and creativity of
in-house research teams are the driving force behind successful upgrades of
numerous existing active molecules. Consequently, Huvepharma has gained a
powerful and worldwide reputation as true innovator in this field. Various EU
and FDA registrations are progressing and are now in their final stages. The
related products will be available to users within next couple of years.<br /><br /> We
have already launched in Europe products from
Tilmovet&reg; and Pharmasin&reg; range.<br /><br /> &nbsp;Need more info? Contact your local Huvepharma representative.</p>]]></description>
 			<pubDate>Mon, 08 Dec 2008 00:00:00 +0200</pubDate>
 		</item>
 		<item>
 			<title>Huvepharma Coccidiosis Symposium</title>
 			<link>http://www.huvepharma.com/news/?n=17</link>
 			<guid>http://www.huvepharma.com/news/?n=17</guid>
 			<description><![CDATA[<p><strong>November 12-th, 2008, Hannover</strong></p>
<p><strong></strong><br /> Huvepharma organized symposium on topic
"Poultry Coccidiosis: Diagnosis and Control Approaches" during Eurotier. The
lecture was held by Prof. Hafez from Germany.</p>
<p>Approximately 120 attendees of the
symposium enjoyed the thorough presentation of Prof. Hafez and the following
nice dinner.</p>
<p>Special thanks to Prof. Hafez for his kind
cooperation!</p>]]></description>
 			<pubDate>Mon, 08 Dec 2008 00:00:00 +0200</pubDate>
 		</item>
 		<item>
 			<title>... There are 101 reasons not to miss it!</title>
 			<link>http://www.huvepharma.com/news/?n=15</link>
 			<guid>http://www.huvepharma.com/news/?n=15</guid>
 			<description><![CDATA[<p>Huvepharma has been building a strong and highly valued image in the
worldwide livestock industry. We have proven to be a trustworthy partner by giving our customers the
benefit of our extensive and continuously enlarging product portfolio.</p>
<p>One of our major strengths is the direct and reliable way we do business
with our partners and customers. We are committed to find new and improved applications and formulations.</p>
<p>This commitment has resulted in a completely new and unprecedented
concept of anticoccidial use in the EU. Therefore, we kindly invite you to our booth on Eurotier 2008, where we
will tell you all about the newest developments. We look forward to welcoming you on our booth<strong> 14C11</strong> in Hall 14.<br /><br /> <strong>The Huvepharma Team</strong></p>]]></description>
 			<pubDate>Mon, 27 Oct 2008 00:00:00 +0200</pubDate>
 		</item>
 		<item>
 			<title>New Huvepharma office opened in Bangkok, Thailand on July 4-th</title>
 			<link>http://www.huvepharma.com/news/?n=14</link>
 			<guid>http://www.huvepharma.com/news/?n=14</guid>
 			<description><![CDATA[<p>Huvepharma (Thailand) Ltd. cooperated with
Department of Livestock Development (DLD) to organize the "Food Safety
Congress" on the 4<sup>th</sup> of July, 2008 in Bangkok and Dr. Alain Kanora,
Global Marketing Director, was also one of our key speakers to present valuable
information on topic of "Situation of Food Safety in EU" how could our products
assure them about food safety. More than 500 participants were Veterinarians,
Animal Husbandries, Farmers, and Feed mill staff members to attend this
congress.<br /><br /> In addition, Huvepharma (Thailand) also had a
great event of Grand Opening Ceremony in the evening on the same day. Most of
our customers appreciated and had excellent time with us.  We really impressed our customers'
responsiveness and look forward to doing greater business with them in the
months ahead.<br /><br /> <strong>We strongly commit that "WE ADD PERFORMANCE TO THEIR BUSINESS".</strong></p>
<ul class="gallery">
<li><a rel="lightbox[0]" href="http://huvepharma.com/images/news/posted/bangkok/IMG_7574.jpg"><img src="http://huvepharma.com/images/news/posted/bangkok/tn/IMG_7574.jpg" alt="huvepharma" /></a></li>
<li><a rel="lightbox[0]" href="http://huvepharma.com/images/news/posted/bangkok/IMG_7616.jpg"><img src="http://huvepharma.com/images/news/posted/bangkok/tn/IMG_7616.jpg" alt="huvepharma" /></a></li>
<li><a rel="lightbox[0]" href="http://huvepharma.com/images/news/posted/bangkok/IMG_7619.jpg"><img src="http://huvepharma.com/images/news/posted/bangkok/tn/IMG_7619.jpg" alt="huvepharma" /></a></li>
<li><a rel="lightbox[0]" href="http://huvepharma.com/images/news/posted/bangkok/IMG_7752.jpg"><img src="http://huvepharma.com/images/news/posted/bangkok/tn/IMG_7752.jpg" alt="huvepharma" /></a></li>
<li><a rel="lightbox[0]" href="http://huvepharma.com/images/news/posted/bangkok/P1090314.jpg"><img src="http://huvepharma.com/images/news/posted/bangkok/tn/P1090314.jpg" alt="huvepharma" /></a></li>
<li><a rel="lightbox[0]" href="http://huvepharma.com/images/news/posted/bangkok/P1090339.jpg"><img src="http://huvepharma.com/images/news/posted/bangkok/tn/P1090339.jpg" alt="huvepharma" /></a></li>
</ul>]]></description>
 			<pubDate>Mon, 04 Aug 2008 00:00:00 +0300</pubDate>
 		</item>
 		<item>
 			<title>Huvepharma at IPVS 2008</title>
 			<link>http://www.huvepharma.com/news/?n=12</link>
 			<guid>http://www.huvepharma.com/news/?n=12</guid>
 			<description><![CDATA[<p>Huvepharma&nbsp;took part in the scientific program during 20th International Pig Veterinary Society Congress IPVS 2008.</p>
<p>The congress&nbsp;has been&nbsp;held from 22nd to 26th of June in the International Convention Centre in Durban, South Africa.</p>]]></description>
 			<pubDate>Mon, 09 Jun 2008 00:00:00 +0300</pubDate>
 		</item>
 		<item>
 			<title>Huvepharma at WPC 2008</title>
 			<link>http://www.huvepharma.com/news/?n=13</link>
 			<guid>http://www.huvepharma.com/news/?n=13</guid>
 			<description><![CDATA[<p>Huvepharma attended the 23rd World's Poultry Congress which&nbsp;has been&nbsp;held in Queensland, Australia from 30 June - 4 July 2008.</p>
<p>The venue for this international event&nbsp;was the Brisbane Convention &amp; Exhibition Center in Brisbane.</p>
<p>&nbsp;</p>]]></description>
 			<pubDate>Mon, 09 Jun 2008 00:00:00 +0300</pubDate>
 		</item>
 		<item>
 			<title>New name of our subsidiary in Poland</title>
 			<link>http://www.huvepharma.com/news/?n=9</link>
 			<guid>http://www.huvepharma.com/news/?n=9</guid>
 			<description><![CDATA[<p>Our subsidiary in Poland, Agri-Biovet, managed by Mr. Maciej Nowak, has recently changed its name to Huvepharma Polska.<br /><br /> Learn more at <a href="http://www.huvepharma.pl">www.huvepharma.pl</a>.</p>]]></description>
 			<pubDate>Fri, 09 May 2008 00:00:00 +0300</pubDate>
 		</item>
 		<item>
 			<title>Coxidin 200 microGranulate<br/>60 ppm (inclusion rate 300 gram/ton)  NEW Brand specific approval in Turkeys</title>
 			<link>http://www.huvepharma.com/news/?n=7</link>
 			<guid>http://www.huvepharma.com/news/?n=7</guid>
 			<description><![CDATA[<p>Coxidin 200 microGranulate is effective against main coccidia species present in Turkeys: Eimeria adenoides, Eimeria meleagrimitis, Eimeria gallopavonis, Eimeria dispersa.</p>
<p>Coxidin 200 microGranulate at doses of minimum 60 ppm and maximum 100 ppm allows a few oocysts to survive and helps the young turkeys to build up a natural immunity.</p>
<p>Coxidin 200 microGranulate contains the world's most widely used molecule as anticoccidial - monensin.</p>
<p>Coxidin<strong><em> </em></strong>200 microGranulate is produced in accordance to EU quality standards.</p>
<p>&nbsp;</p>]]></description>
 			<pubDate>Tue, 26 Feb 2008 00:00:00 +0200</pubDate>
 		</item>
 		<item>
 			<title>New office opened in Moscow, Russia</title>
 			<link>http://www.huvepharma.com/news/?n=4</link>
 			<guid>http://www.huvepharma.com/news/?n=4</guid>
 			<description><![CDATA[<p>At the end of 2007 Huvepharma makes a strategic move into the Russian market and opens a representative office in Moscow. The world's tenth-largest economy, Russia's tremendous potential in agriculture with growing domestic demand make the country a valuable market for whole range of Huvepharma products. Positive image of Huvepharma feed additives and animal health products will be fortified with activities of Russian sales team to increase in market share. The team has total of 8 skilled professionals; 4 of which are the field force, who not only received Master Degrees in Veterinary Medicine, but have also had years of practice in different fields - both in farm animal industry and veterinary wholesale business. They have been hired in key regions (Siberia, Ural, South and Center of Russia) allowing to provide qualified support for customers and dealer network altogether. Management team is experienced in business development, so they're able to achieve most ambitious goals - even in unpredictable country such as Russia.</p>]]></description>
 			<pubDate>Tue, 22 Jan 2008 00:00:00 +0200</pubDate>
 		</item>
 		<item>
 			<title>Huvepharma has launched HostazymŽ suis in January 2008</title>
 			<link>http://www.huvepharma.com/news/?n=2</link>
 			<guid>http://www.huvepharma.com/news/?n=2</guid>
 			<description><![CDATA[<p>Hostazym&reg; suis is a natural, multi-enzyme complex with mainly endo1, 4-beta glucanase activity, used in pig feed. This complex is produced through Solid State Fermentation process (SSF) using specific strain of Trichoderma longibrachiatum.</p>
<p>Hostazym&reg; suis is an excellent enzyme for weaned piglets and growers, fed diets which include cereals like barley, wheat, rye, triticale and soya. Addition of enzymes to pig diets makes it possible to include high levels of cost-benefit cereals, ingredients which otherwise would not be optimally digested.</p>
<p>Hostazym &reg; suis is used in pre-starter, starter and weaner feed.</p>
<p>Hostazym&reg; suis improves both weight gain and feed conversion.</p>
<p>Hostazym&reg; suis helps safeguard health and performance.</p>]]></description>
 			<pubDate>Mon, 21 Jan 2008 00:00:00 +0200</pubDate>
 		</item>
 		<item>
 			<title>Merial sells St. Louis pharmaceutical blending facility to Huvepharma</title>
 			<link>http://www.huvepharma.com/news/?n=1</link>
 			<guid>http://www.huvepharma.com/news/?n=1</guid>
 			<description><![CDATA[<p>Duluth, Ga., May 4, 2007 - Merial, Limited, and Huvepharma, Inc. announced that Merial has sold its St. Louis blending facility and rights to certain anticoccidial products to Huvepharma.  The sale was effective April 27, 2007.  </p>
<p>Huvepharma and Merial have also reached an agreement for transfer of marketing rights for a number of products manufactured at the site, which are mainly anticoccidials for use in poultry:</p>
<ul>
	<li>AMPROL&reg; (amprolium) 25% Premix</li>
	<li>AMPROL&reg; 20% Soluble Powder</li>
	<li>AMPROL&reg; 9.6% Solution</li>
	<li>AMPROL&reg; (amprolium/ethopabate) Plus</li>
	<li>COYDEN&reg; (clopidol) 25% Premix</li>
</ul>
<p>AMPROL&reg;, COYDEN and CORID are registered trademarks of Merial.</p>
<p>As part of the agreement, Huvepharma will also supply Merial with certain cattle anticoccidial products, which are also manufactured at the site.  These products bear the CORID&reg; (amprolium) trademark.</p>
]]></description>
 			<pubDate>Fri, 04 May 2007 00:00:00 +0300</pubDate>
 		</item>
	
	</channel>
</rss>